NCT04727021 - A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 4, 2017

Primary Completion Date

September 4, 2017

Study Completion Date

October 27, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

20 mg tablet rivaroxaban

Single oral dose of a 20 mg tablet rivaroxaban, administered under fed conditions

DRUG

20 mg rivaroxaban, granules for oral suspension

Single oral dose of 20 mg rivaroxaban, granules for oral suspension administered under fed conditions.

Trial Locations (1)

CRS Clinical-Research-Services Mönchengladbach GmbH, Mönchengladbach